3D tumor cultures for drug resistance and screening development in clinical applications
Abstract Tumor drug resistance presents a growing challenge in medical practice, particularly during anti-cancer therapies, where the emergence of drug-resistant cancer cells significantly complicates clinical treatment. In recent years, three-dimensional (3D) tumor culture technology, which more ef...
Saved in:
| Main Authors: | Zheng Peng, Xiaolan Lv, Hao Sun, Lina Zhao, Shigao Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02281-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy
by: Yan Zhou, et al.
Published: (2025-08-01) -
A novel organoid model retaining the glioma microenvironment for personalized drug screening and therapeutic evaluation
by: Chengjun Zheng, et al.
Published: (2025-11-01) -
Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening
by: Lisa Götz, et al.
Published: (2025-02-01) -
Patient‐Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment
by: Hongda Zhao, et al.
Published: (2025-04-01) -
Harnessing organoid technology in urological cancer: advances and applications in urinary system tumors
by: Xiaoting Wang, et al.
Published: (2025-07-01)